MYFEMBREE is a medication used to manage conditions such as heavy menstrual bleeding caused by uterine fibroids and moderate to severe pain associated with endometriosis in premenopausal women. It combines three active ingredients: relugolix, a GnRH receptor antagonist; estradiol, an estrogen; and norethindrone acetate, a progestin. MYFEMBREE reduces hormone levels to alleviate symptoms related to these conditions. However, due to potential risks such as bone loss, treatment should be limited to a period of 24 months.

The medication is available as a fixed-dose combination tablet, and it is crucial to follow the prescribed dosage and administration instructions, including excluding pregnancy before starting treatment. The use of MYFEMBREE can cause side effects, so monitoring and proper medical advice are important throughout treatment.